Suicidal overdose of dolutegravir: A case report
Dolutegravir (DTG) is the most recently introduced integrase inhibitor for the treatment of HIV infection and is preferred for its superior tolerability and efficacy in both new and pre-treated patients, and infrequent drug interactions. Since January 2017, Botswana has adopted a ‘treat-all’ approac...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
AOSIS
2018-06-01
|
| Rangatū: | Southern African Journal of HIV Medicine |
| Ngā marau: | |
| Urunga tuihono: | https://sajhivmed.org.za/index.php/hivmed/article/view/799 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|